Back
Amicus Therapeutics Stock Price Chart
Market's down 10% YTD Buffet's Berkshire up 13%
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
9
FOLD
Amicus Therapeutics
Last Price:
$6.82
Seasonality Move:
10.9%
7 Day Trial
ALL ACCESS PASS
$
7
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOLD is experiencing selling pressure, which indicates risk of future bearish movement.
Amicus Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.76 | Sell |
| 20-day SMA: | 7.73 | Sell |
| 50-day SMA: | 8.68 | Sell |
| 200-day SMA: | 10.01 | Sell |
| 8-day EMA: | 6.92 | Sell |
| 20-day EMA: | 7.53 | Sell |
| 50-day EMA: | 8.37 | Sell |
| 200-day EMA: | 9.73 | Sell |
Amicus Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.63 | Sell |
| Relative Strength Index (14 RSI): | 28.54 | Sell |
| Chaikin Money Flow: | -2086382 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.04 - 8.92) | Sell |
| Bollinger Bands (100): | (8.3 - 10.02) | Sell |
Amicus Therapeutics Technical Analysis
| Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Amicus Therapeutics Stock
Is Amicus Therapeutics Stock a Buy?
-
Amicus Therapeutics share price is 6.70 while FOLD 8-day simple moving average is 6.76, which is a Sell signal.
-
The stock price of FOLD is 6.70 while Amicus Therapeutics 20-day SMA is 7.73, which makes it a Sell.
-
Amicus Therapeutics 50-day simple moving average is 8.68 while FOLD share price is 6.70, making it a Sell technically.
-
FOLD stock price is 6.70 and Amicus Therapeutics 200-day simple moving average is 10.01, creating a Sell signal.
FOLD Technical Analysis vs Fundamental Analysis
Sell
9
Amicus Therapeutics (FOLD)
is a Sell
Is Amicus Therapeutics a Buy or a Sell?
-
Amicus Therapeutics stock is rated a SellThe current Amicus Therapeutics [FOLD] share price is $6.70. The Score for FOLD is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
Amicus Therapeutics Stock Info
Market Cap:
2.1B
Price in USD:
6.70
Share Volume:
3.3M
Amicus Therapeutics 52-Week Range
52-Week High:
12.65
52-Week Low:
6.20
Sell
9
Amicus Therapeutics (FOLD)
is a Sell
Amicus Therapeutics Share Price Forecast
-
What is the Amicus Therapeutics stock price today?The Amicus Therapeutics stock price is 6.70 USD today.
-
Will FOLD stock go up or go down?Amicus Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Amicus Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Amicus Therapeutics is overvalued.
Is Amicus Therapeutics Stock a Buy?
-
Amicus Therapeutics share price is 6.70 while FOLD 8-day exponential moving average is 6.92, which is a Sell signal.
-
The stock price of FOLD is 6.70 while Amicus Therapeutics 20-day EMA is 7.53, which makes it a Sell.
-
Amicus Therapeutics 50-day exponential moving average is 8.37 while FOLD share price is 6.70, making it a Sell technically.
-
FOLD stock price is 6.70 and Amicus Therapeutics 200-day simple moving average is 9.73, creating a Sell signal.
Fundamental Analysis of Amicus Therapeutics
Is Amicus Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.27 per share, and an increase next year of $0.33 per share.
Technical Analysis of Amicus Therapeutics
Should I short Amicus Therapeutics stock?
-
FOLD Moving Average Covergence Divergence (MACD) indicator is -0.63, suggesting Amicus Therapeutics is a Sell
-
Amicus Therapeutics Relative Strength Index (RSI) is 28.54, which suggest Amicus Therapeutics is oversold
-
The Bollinger Bands (25) for Amicus Therapeutics is (7.04 - 8.92), which suggest Amicus Therapeutics is a Sell
-
The Bollinger Bands (100) for Amicus Therapeutics is (8.3 - 10.02), which suggest Amicus Therapeutics is a Sell
* Amicus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.